Optima Capital’s Gilead Sciences GILD Stock Holding History

Optima Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$216K	Buy	1,708 +13	+0.8%	+$1.71K	0.09%	152
2026 Q1	$236K	Buy	1,695 +18	+1%	+$2.52K	0.11%	147
2025 Q4	$206K	Sell	1,677 -239	-12%	-$29K	0.09%	155
2025 Q3	$213K	Buy	1,916 +24	+1%	+$2.73K	0.1%	151
2025 Q2	$210K	Buy	1,892 +18	+1%	+$1.92K	0.11%	149
2025 Q1	$210K	Buy	+1,874	New	+$193K	0.13%	134

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Optima Capital's GILD Position: Q2 2026 in Review

Optima Capital increased its Gilead Sciences (GILD) stake by 0.77% in Q2 2026, buying an estimated $1.71K and bringing the position to 1,708 shares worth $216K. The position accounts for 0.09% of the portfolio, ranked #152.

Optima Capital first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $236K in Q1 2026. 691 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Optima Capital held 1,708 shares of Gilead Sciences worth $216K as of Q2 2026.
Optima Capital bought 13 Gilead Sciences shares in Q2 2026, an estimated $1.71K.
Gilead Sciences made up 0.09% of Optima Capital's portfolio in Q2 2026, its #152 holding.
Optima Capital first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
Optima Capital's Gilead Sciences position peaked at $236K in Q1 2026.
691 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Optima Capital's 13F filing for Q2 2026, filed 24 Jul 2026.